Mark Carnegie-Brown (Oxitec): Advanced genetics & molecular biology for Aedes control
At the annual ISNTD Bites conference on vector-borne diseases and vector control, Mark Carnegie-Brown, CEO at Oxitec, speaks about the impact of Oxitec's genetic and molecular solutions on controlling populations of Aedes mosquitoes as well as Aedes-borne diseases.
Recorded at ISNTD Bites 2017 on July 19th at the Institute of Child Health, London.
Recorded at ISNTD Bites 2017 on July 19th at the Institute of Child Health, London.
…………………………………………………….
For more information please contact:
Kamran Rafiq
krafiq@isntd.org
